About the Journal

International Journal of Research in Oncology and Hematology (IJRIOH) is a Double Blind Peer reviewed open access journal. that provides publication of articles in following scope.

Focus and Scope

Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:

  • Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders         
  • Diagnostic investigations, including imaging and laboratory assays
  • Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases
  • Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies
  • Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.
  • Basic Experimental Oncology, Career Development and Education in Oncology, Clinical Research, Hematology, Immunotherapy, Molecular Pathology, Genomics and omics, and Liquid Biopsy
  • Palliative Support, Pediatric Oncology, Radiotherapy, Regulatory, Ethics, and Health Policy, Solid Tumors, Statistics, Meta-analysis, and Clinical Trial Design, Surgery
  • Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.

The International Journal of Research in Oncology and Hematology (IJRIOH) is published Bi-Annually (one volume per year) by HM Journals.

Reasons to publish with us:

  • Simple, drag & drop submissions process, offering clear author guidelines for easy preparation of your manuscript.
  • Read and trusted globally by hematologists, oncologists, radiotherapists, and pathologists.
  • Uses ORCiD IDs, making your work more discoverable.

All Articles invited or submitted spontaneously, are subject to peer review before final acceptance. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Author Guidelines.